HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takahashi, N. Articles by Chari, S. T. Search for Related Content PubMed PubMed Citation Articles by Takahashi, N. Articles by Chari, S. T. Social Bookmarking                      What's this?

Dual-Phase CT of Autoimmune Pancreatitis: A Multireader Study

¹ Department of Radiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905.
² Department of Internal Medicine, Mayo Clinic, Rochester, MN.

OBJECTIVE. The purpose of this study was to identify findings that aid in differentiating autoimmune pancreatitis from pancreatic carcinoma using dual-phase CT.

MATERIALS AND METHODS. Dual-phase CT scans of 74 patients (25 with autoimmune pancreatitis, 33 with pancreatic carcinoma, and 16 with a normal pancreas) were independently evaluated by three radiologists for enhancement of the pancreas; the presence of a capsule-like rim, peripancreatic strands, and pancreatic calcifications; pancreatic duct or bile duct changes; and renal involvement. The frequency of CT characteristics was compared between autoimmune pancreatitis and carcinoma. Interobserver agreement for the three reviewers for the assessment of CT characteristics was evaluated using kappa statistics.

RESULTS. Diffusely decreased enhancement of the pancreas (autoimmune pancreatitis vs carcinoma: 28% vs 3%; p = 0.02, = 0.33–0.75), capsule–like rim (40% vs 9%; p = 0.009, = 0.42–0.66), peripancreatic strands (60% vs 27%; p = 0.02, = 0.45–0.54), pancreatic calcifications (32% vs 9%; p = 0.04, = 0.14–0.47), bile duct wall enhancement (52% vs 6%; p = 0.0001, = 0.28–0.47), and renal involvement (28% vs 0%; p = 0.002, = 0.32–0.74) were more frequent in patients with autoimmune pancreatitis. Pancreatic duct dilation (24% vs 67%; p = 0.001, = 0.65–0.73) and abrupt cutoff (16% vs 55%; p = 0.003, = 0.60–0.65) were more frequent in patients with carcinoma.

CONCLUSION. Diffusely decreased enhancement of the pancreas, a capsule-like rim, bile duct enhancement, and renal involvement are useful signs of autoimmune pancreatitis.

Keywords: autoimmune pancreatitis • CT • gastrointestinal tract • pancreas • pancreatic carcinoma

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S-H Moon, M-H Kim, D H Park, C Y Hwang, S J Park, S S Lee, D W Seo, and S K Lee Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study Gut, December 1, 2008; 57(12): 1704 - 1712. [Abstract] [Full Text] [PDF]